Trial Profile
The efficacy and tolerability of Galvus (Vildagliptin) compared to Sulfonylureas in patients with new onset diabetes after transplantation (NODAT)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Gliclazide
- Indications Diabetes mellitus
- Focus Adverse reactions; Biomarker
- Acronyms VAT
- 13 Apr 2013 New trial record